Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;31(7):1320-33.
doi: 10.1002/jbmr.2800. Epub 2016 Mar 4.

Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG

Song Xu  1   2 , Yue Zhang  1   2 , Bin Liu  3 , Kai Li  1 , Bin Huang  2 , Bo Yan  2 , Zhongmin Zhang  2 , Kangyan Liang  1 , Chunhong Jia  1 , Jun Lin  1 , Chun Zeng  2 , Daozhang Cai  2 , Dadi Jin  2 , Yu Jiang  4 , Xiaochun Bai  1   2
Affiliations
Free article

Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG

Song Xu et al. J Bone Miner Res. 2016 Jul.
Free article

Abstract

The cytokine receptor activator of nuclear factor-κB ligand (RANKL) induces osteoclast formation from monocyte/macrophage lineage cells. However, the mechanisms by which RANKL expression is controlled in cells that support osteoclast differentiation are still unclear. We show that deletion of TSC1 (tuberous sclerosis complex 1) in murine B cells causes constitutive activation of mechanistic target of rapamycin complex 1 (mTORC1) and stimulates RANKL but represses osteoprotegerin (OPG) expression and subsequently promotes osteoclast formation and causes osteoporosis in mice. Furthermore, the regulation of RANKL/OPG and stimulation of osteoclastogenesis by mTORC1 was confirmed in a variety of RANKL-expressing cells and in vivo. Mechanistically, mTORC1 controls RANKL/OPG expression through negative feedback inactivation of Akt, destabilization of β-catenin mRNA, and downregulation of β-catenin. Our findings demonstrate that mTORC1 activation-stimulated RANKL expression in B cells is sufficient to induce bone loss and osteoporosis. The study also established a link between mTORC1 and the RANKL/OPG axis via negative regulation of β-catenin. © 2016 American Society for Bone and Mineral Research.

Keywords: B LYMPHOCYTE; OSTEOCLAST FORMATION; RANKL (RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-κB LIGAND); mTORC1 (MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1); β-CATENIN.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms